Management of Patients With Refractory Ascites.
作者信息
Asrani Sumeet
机构信息
Chief of Hepatology and Liver Transplantation Baylor Simmons Transplant Institute Baylor Dallas and Fort Worth, Texas.
出版信息
Gastroenterol Hepatol (N Y). 2025 Jul;21(7):431-433.
Abstract
摘要
相似文献
1
Management of Patients With Refractory Ascites.难治性腹水患者的管理
Gastroenterol Hepatol (N Y). 2025 Jul;21(7):431-433.
2
Benefits of TIPS for Patients With Large Ascites Preceding Recurrent or Refractory ascites: A Multicenter Cohort Study.经颈静脉肝内门体分流术（TIPS）对复发性或难治性腹水之前大量腹水患者的益处：一项多中心队列研究。
J Gastroenterol Hepatol. 2025 Jun;40(6):1574-1585. doi: 10.1111/jgh.16948. Epub 2025 Mar 26.
3
TIPS versus paracentesis for cirrhotic patients with refractory ascites.经颈静脉肝内门体分流术与腹腔穿刺术治疗肝硬化难治性腹水的比较
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD004889. doi: 10.1002/14651858.CD004889.pub2.
4
Covered TIPS Created with Viatorr Versus Fluency Stent-Grafts for the Refractory Ascites in Patients with Cirrhosis: An Observational Study.使用Viatorr覆膜支架与Fluency覆膜支架治疗肝硬化顽固性腹水的观察性研究
Acad Radiol. 2025 May 5. doi: 10.1016/j.acra.2025.04.033.
5
TIPS versus paracentesis for cirrhotic patients with refractory ascites.经颈静脉肝内门体分流术（TIPS）与腹腔穿刺术治疗肝硬化难治性腹水的比较
Cochrane Database Syst Rev. 2004(3):CD004889. doi: 10.1002/14651858.CD004889.
6
Nonselective β-Blockers and Survival in Patients With Cirrhosis and Ascites: A Systematic Review and Meta-analysis.非选择性β受体阻滞剂与肝硬化伴腹水患者生存：系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1096-1104.e9. doi: 10.1016/j.cgh.2016.01.012. Epub 2016 Jan 30.
7
Acute kidney injury incidence and clinical features: Refractory versus non-refractory ascites.
Ann Hepatol. 2025 May 22;30(2):101922. doi: 10.1016/j.aohep.2025.101922.
8
The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.经颈静脉肝内门体分流术治疗肝硬化难治性腹水
Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):380-9. doi: 10.1038/ncpgasthep0523.
9
Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis.失代偿期肝硬化行 Denver 腹膜静脉分流术后的时间进程和临床特征。
Tomography. 2024 Mar 25;10(4):471-479. doi: 10.3390/tomography10040036.
10
Using the Alfapump® to control ascites enabling elective umbilical hernia repair: A case report.使用Alfapump®控制腹水以实现择期脐疝修补术：一例报告。
Hernia. 2025 Jun 18;29(1):209. doi: 10.1007/s10029-025-03393-w.
本文引用的文献
1
Management of ascites and volume overload in patients with cirrhosis.肝硬化患者腹水及容量超负荷的管理
Clin Liver Dis (Hoboken). 2024 Feb 9;23(1):e0115. doi: 10.1097/CLD.0000000000000115. eCollection 2024 Jan-Jun.
2
North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension.北美门静脉高压经颈静脉肝内门体分流术实践推荐
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1636-1662.e36. doi: 10.1016/j.cgh.2021.07.018. Epub 2021 Jul 15.
3
Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.腹水、自发性细菌性腹膜炎和肝肾综合征的诊断、评估及管理：美国肝病研究协会2021年实践指南
Hepatology. 2021 Aug;74(2):1014-1048. doi: 10.1002/hep.31884.
4
Systematic review with meta-analysis: automated low-flow ascites pump therapy for refractory ascites.系统评价与荟萃分析：自动化低流量腹水泵治疗难治性腹水。
Aliment Pharmacol Ther. 2019 Nov;50(9):978-987. doi: 10.1111/apt.15502. Epub 2019 Oct 3.
5
Refractory Ascites in Liver Cirrhosis.肝硬化难治性腹水。
Am J Gastroenterol. 2019 Jan;114(1):40-47. doi: 10.1038/s41395-018-0185-6.
6
Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.Alfapump® 系统与大量腹腔穿刺放液治疗难治性腹水的比较：一项多中心随机对照研究。
J Hepatol. 2017 Nov;67(5):940-949. doi: 10.1016/j.jhep.2017.06.010. Epub 2017 Jun 21.
Zotero 插件